Lila-Sabrina Fetita

Clinical research director
Sanofi Genzyme, Paris, France

Presentation(s):

• OC 50.2 - Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin: Analysis of Antithrombin Levels and Thrombin Generation from a Phase 3 Study in People with Hemophilia A or B Without inhibitors

  Tuesday, July 12, 2022
  11:00 AM – 11:15 AM